CNPV
CLBP trial , overwhelming efficacy at a 6 month read out of say 200 of the 300 patients, could lead to most of the BLA being filed early.
Opioid epidemic is #1 National Health Issue. MAHA
Think 2027 approval not 2029.
Reg
- Forums
- ASX - By Stock
- Ann: Mesoblast Maintains Momentum with FDA
MSB
mesoblast limited
Add to My Watchlist
2.25%
!
$1.63

CNPV CLBP trial , overwhelming efficacy at a 6 month read out of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
-0.038(2.25%) |
Mkt cap ! $2.089B |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.62 | $7.179M | 4.378M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 15664 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 90248 | 52 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 16270 | 1.630 |
26 | 48050 | 1.625 |
22 | 78687 | 1.620 |
10 | 91610 | 1.615 |
17 | 72417 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 89658 | 52 |
1.640 | 42986 | 19 |
1.645 | 73923 | 9 |
1.650 | 100948 | 7 |
1.655 | 29696 | 7 |
Last trade - 15.08pm 20/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |